EN 中文
Home Strategic Partnerships News Contact us
TOTAL:77 NEWS
Zhaoke Ophthalmology Commences Commercialisation of its First Drug with Bimatoprost Timolol Eye Drop (晶贝莹®) Obtaining Marketing Authorization from the National Medical Products Administration
read
2023-02-20
3949
Zhaoke Ophthalmology’s Cyclosporine A (CsA) Ophthalmic Gel Passed the Onsite Regulatory and Clinical Trial Inspections by the NMPA, and the GMP Compliance Inspection by the Guangdong Medical Products Administration
read
2023-02-01
2244
兆科眼科荣获第五届粤港澳大湾区生物科技创新企业50强评选“领军企业”奖项
read
2022-12-29
2003
Zhaoke Ophthalmology Won the “Best Small and Mid-Cap Company” Award at the “Embracing 2023: the Seventh Golden Hong Kong Stocks Annual Awards Ceremony”
read
2022-12-23
1963
Zhaoke Ophthalmology Reaches Exclusive Distribution Agreement to Commercialize TONO-i in Greater China for Self-Measurement of Intraocular Pressure
read
2022-11-09
3338
>

Guangzhou Headquarters
Tel: 020-39062828
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat